Maayan Gruber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maayan Gruber has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
Eyal Sela
Department of Otolaryngology–Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel
6 shared publicationsMurali Mahadevan
Paediatric Otolaryngology, Starship Children's Hospital, Auckland, New Zealand
4 shared publications- Netanel Eisenbach
Department of Otolaryngology-Head and Neck Surgery, McGill University Health Center, Montreal, QC H4A 0B1, Canada
4 shared publications - Aiman Abu Ammar
Department of Pharmaceutical Engineering, Azrieli College of Engineering Jerusalem, Jerusalem 9103501, Israel
3 shared publications Michel Neeff
Paediatric Otolaryngology, Starship Children's Hospital, Auckland, New Zealand
3 shared publications- Ohad Ronen
Azrieli Faculty of Medicine Bar‐Ilan University Safed Israel
3 shared publications
Latest Publications
- 23 May 2026
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 135 (11) , 842-849
Safety and Efficacy of a Novel Radiofrequency Device for Submucosal Turbinate Reduction - A Prospective, Open-Label Pilot Trial
Objective: Inferior turbinate (IT) hypertrophy is a major cause of nasal obstruction. Although surgical intervention is effective, it can be associated with morbidity and prolonged recovery. This study evaluated the safety, efficacy, and tolerability of a novel submucosal fractional radiofrequency (FRF) treatment. Methods: A prospective, single-arm, open-label study was conducted from March to November 2024. Patients with nasal obstruction caused by IT hypertrophy unresponsive to at least 1 month of medical treatment were included in the study. The procedure was performed endoscopically under topical anesthesia using FRF. Outcomes were assessed using the Nasal Obstruction Symptom Evaluation (NOSE) scale, Visual Analog Scale (VAS), and endoscopic turbinate grading at baseline, 1 month, and 3 months after the procedure. The safety outcomes included pain scale, adverse events, and complications. Results: A total of 22 patients completed the protocol. The NOSE score improved from 71.2 to 30.0 at 1 month ( P < .001). Sustained NOSE score improvement was observed at 3 months (37.1, P < .001). The VAS scores for nasal obstruction decreased from 7.4 to 3.2 at 1 month and 3.9 at 3 months ( P < .0001). Endoscopic grading of turbinate size demonstrated a reduction at both follow-up points ( P < .05). The average VAS score for pain was 3.4, indicating good tolerability. No bleeding, synechiae, or other adverse events were reported. Crusting appeared in 50% of patients at 1 month, resolving in all but 1 patient by 3 months. A significant correlation was observed between the pulse count and symptom improvement ( P = .02). Conclusion: Submucosal FRF treatment leads to significant and sustained improvement in nasal obstruction with minimal pain and no major adverse events. These results support the safety, efficacy, and tolerability of the procedure for IT hypertrophy in an outpatient setting. Larger cohorts and long-term follow-up studies are warranted to refine the treatment and further validate these findings. Level of evidence: 3
- 23 May 2026
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 135 (11) , 842-849
Safety and Efficacy of a Novel Radiofrequency Device for Submucosal Turbinate Reduction - A Prospective, Open-Label Pilot Trial
Objective: Inferior turbinate (IT) hypertrophy is a major cause of nasal obstruction. Although surgical intervention is effective, it can be associated with morbidity and prolonged recovery. This study evaluated the safety, efficacy, and tolerability of a novel submucosal fractional radiofrequency (FRF) treatment. Methods: A prospective, single-arm, open-label study was conducted from March to November 2024. Patients with nasal obstruction caused by IT hypertrophy unresponsive to at least 1 month of medical treatment were included in the study. The procedure was performed endoscopically under topical anesthesia using FRF. Outcomes were assessed using the Nasal Obstruction Symptom Evaluation (NOSE) scale, Visual Analog Scale (VAS), and endoscopic turbinate grading at baseline, 1 month, and 3 months after the procedure. The safety outcomes included pain scale, adverse events, and complications. Results: A total of 22 patients completed the protocol. The NOSE score improved from 71.2 to 30.0 at 1 month ( P < .001). Sustained NOSE score improvement was observed at 3 months (37.1, P < .001). The VAS scores for nasal obstruction decreased from 7.4 to 3.2 at 1 month and 3.9 at 3 months ( P < .0001). Endoscopic grading of turbinate size demonstrated a reduction at both follow-up points ( P < .05). The average VAS score for pain was 3.4, indicating good tolerability. No bleeding, synechiae, or other adverse events were reported. Crusting appeared in 50% of patients at 1 month, resolving in all but 1 patient by 3 months. A significant correlation was observed between the pulse count and symptom improvement ( P = .02). Conclusion: Submucosal FRF treatment leads to significant and sustained improvement in nasal obstruction with minimal pain and no major adverse events. These results support the safety, efficacy, and tolerability of the procedure for IT hypertrophy in an outpatient setting. Larger cohorts and long-term follow-up studies are warranted to refine the treatment and further validate these findings. Level of evidence: 3
- Open Access
- 1 March 2025
- Published by Wiley in Clinical Otolaryngology
- Vol. 50 (4) , 681-689
No Difference in Pain or Febrile Episodes With the Use of Post‐Operative Antibiotics in Paediatric Coblation Intracapsular Tonsillectomy for Sleep‐Disordered Breathing or Recurrent Tonsillitis: A Prospective Randomised Trial
Objective: Coblation technology is gaining wide acceptance and use as a contemporary surgical technique for tonsil surgeries due to less post‐operative morbidity compared to the more traditional total tonsillectomy. Previous articles examined the role of post‐operative antibiotics for traditional total tonsillectomy; however, this is the first study which explores the role of post‐operative prophylactic antibiotic treatment among children undergoing coblation intracapsular tonsillectomy.Methods: A prospective randomised study included 100 children (aged 1–16) who were divided into two subgroups: with and without post‐operative antibiotics. Post‐operative follow‐up of patients included assessment for 7 days of pain levels, fever, return to diet, bleeding and halitosis. In addition, the children's caregivers completed the Parents'‐Postoperative‐Pain‐Measure (PPP‐M) questionnaire on Days 1 and 7.Results: The (+) antibiotic subgroup had substantially less halitosis on Days 2–6 after surgery. Prophylactic antibiotic treatment did not yield any differences between the two subgroups in the incidence of fever, return to regular diet or drinking, pain as measured by the Wong Baker Faces Pain scale, or pain as reported by the parents on the PPP‐M questionnaire.Conclusions: This prospective study highlights that routine prophylactic post‐operative antibiotic use has a limited clinical benefit in paediatric intracapsular tonsillectomy. Improvement in halitosis was significant with antibiotic treatment; however, various other clinical parameters did not differ between the two subgroups, so the routine use of post‐operative antibiotics in the above setting is discouraged.
- 1 March 2025
- Published by Wiley in Clinical Otolaryngology
- Vol. 50 (4) , 681-689
Open AccessNo Difference in Pain or Febrile Episodes With the Use of Post‐Operative Antibiotics in Paediatric Coblation Intracapsular Tonsillectomy for Sleep‐Disordered Breathing or Recurrent Tonsillitis: A Prospective Randomised Trial
Objective: Coblation technology is gaining wide acceptance and use as a contemporary surgical technique for tonsil surgeries due to less post‐operative morbidity compared to the more traditional total tonsillectomy. Previous articles examined the role of post‐operative antibiotics for traditional total tonsillectomy; however, this is the first study which explores the role of post‐operative prophylactic antibiotic treatment among children undergoing coblation intracapsular tonsillectomy.Methods: A prospective randomised study included 100 children (aged 1–16) who were divided into two subgroups: with and without post‐operative antibiotics. Post‐operative follow‐up of patients included assessment for 7 days of pain levels, fever, return to diet, bleeding and halitosis. In addition, the children's caregivers completed the Parents'‐Postoperative‐Pain‐Measure (PPP‐M) questionnaire on Days 1 and 7.Results: The (+) antibiotic subgroup had substantially less halitosis on Days 2–6 after surgery. Prophylactic antibiotic treatment did not yield any differences between the two subgroups in the incidence of fever, return to regular diet or drinking, pain as measured by the Wong Baker Faces Pain scale, or pain as reported by the parents on the PPP‐M questionnaire.Conclusions: This prospective study highlights that routine prophylactic post‐operative antibiotic use has a limited clinical benefit in paediatric intracapsular tonsillectomy. Improvement in halitosis was significant with antibiotic treatment; however, various other clinical parameters did not differ between the two subgroups, so the routine use of post‐operative antibiotics in the above setting is discouraged.
- Open Access
Management of Pediatric Foreign Body Injuries during the COVID-19 Pandemic: Results of an International Survey
The COVID-19 pandemic has had direct and indirect effects on daily life. In hospitals, the impact of the pandemic was observed in the diagnostic and therapeutic workflow. In this work, we explored potential changes in activities related to the treatment of foreign body injuries (FBIs) in children and the behavioral habits of physicians during the first wave of the pandemic. An online survey was conducted among physicians of the Susy Safe network. The survey comprised items related to respondent information, reference center characteristics, the treatment of FBIs during the COVID-19 pandemic, and a modified COVID-19 Anxiety Scale (CAS). The survey was distributed among the Susy Safe project international network surveillance registry for FBIs. A total of 58 physicians responded to the survey, including 18 (32%) from Europe and 16 (28%) from South America. The respondents indicated that the estimated number of aspirated foreign bodies during the pandemic was lower than or the same as that before the pandemic (43, 74%), and the same was observed for ingested foreign bodies (43, 74%). In univariable logistic regression, no single predictor was associated with a delay in routine care for children or an increasing tendency of medical personnel to avoid procedures. The workflow of physicians involved in the management of FBIs in children has not changed drastically during the COVID-19 pandemic, especially in emergency departments.
Open AccessManagement of Pediatric Foreign Body Injuries during the COVID-19 Pandemic: Results of an International Survey
The COVID-19 pandemic has had direct and indirect effects on daily life. In hospitals, the impact of the pandemic was observed in the diagnostic and therapeutic workflow. In this work, we explored potential changes in activities related to the treatment of foreign body injuries (FBIs) in children and the behavioral habits of physicians during the first wave of the pandemic. An online survey was conducted among physicians of the Susy Safe network. The survey comprised items related to respondent information, reference center characteristics, the treatment of FBIs during the COVID-19 pandemic, and a modified COVID-19 Anxiety Scale (CAS). The survey was distributed among the Susy Safe project international network surveillance registry for FBIs. A total of 58 physicians responded to the survey, including 18 (32%) from Europe and 16 (28%) from South America. The respondents indicated that the estimated number of aspirated foreign bodies during the pandemic was lower than or the same as that before the pandemic (43, 74%), and the same was observed for ingested foreign bodies (43, 74%). In univariable logistic regression, no single predictor was associated with a delay in routine care for children or an increasing tendency of medical personnel to avoid procedures. The workflow of physicians involved in the management of FBIs in children has not changed drastically during the COVID-19 pandemic, especially in emergency departments.
- Open Access
- 2 October 2023
- Published by Cambridge University Press (CUP) in Disaster Medicine and Public Health Preparedness
- Vol. 17, e498
Humanitarian Outpatient Pediatric Endeavor (HOPE): A Novel Specialist Ambulatory Health-Care Concept in Conflict Areas
With the collapse of the medical system in Syria, Israel began providing Syrians with humanitarian aid, first to the war-injured and then general medical treatment. We developed a novel specialist ambulatory care concept to provide medical care for Syrian children. Children with their caregivers were transported by bus across the border from Syria to our medical center in Israel for day-stay outpatient-clinic advanced evaluation and treatment due to coordination between Syrian, Red Cross, and Israeli authorities, including Israeli Defense Forces. This retrospective field report includes 371 Syrian children treated as outpatients at Galilee Medical Center between January 2016 and September 2018. In our experience, this novel pediatric ambulatory care concept has been feasible, efficient, and successful in providing specialist care for children in a crisis region devoid of access to health care. We believe it can also serve adult patients and be implemented in other crises and disasters scenarios.
- 2 October 2023
- Published by Cambridge University Press (CUP) in Disaster Medicine and Public Health Preparedness
- Vol. 17, e498
Open AccessHumanitarian Outpatient Pediatric Endeavor (HOPE): A Novel Specialist Ambulatory Health-Care Concept in Conflict Areas
With the collapse of the medical system in Syria, Israel began providing Syrians with humanitarian aid, first to the war-injured and then general medical treatment. We developed a novel specialist ambulatory care concept to provide medical care for Syrian children. Children with their caregivers were transported by bus across the border from Syria to our medical center in Israel for day-stay outpatient-clinic advanced evaluation and treatment due to coordination between Syrian, Red Cross, and Israeli authorities, including Israeli Defense Forces. This retrospective field report includes 371 Syrian children treated as outpatients at Galilee Medical Center between January 2016 and September 2018. In our experience, this novel pediatric ambulatory care concept has been feasible, efficient, and successful in providing specialist care for children in a crisis region devoid of access to health care. We believe it can also serve adult patients and be implemented in other crises and disasters scenarios.
- 12 April 2021
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 4 (5) , 4131-4139
Local Delivery of Mometasone Furoate from an Eluting Endotracheal Tube Reduces Airway Morbidity Following Long-Term Animal Intubation
Background: upper airway complications are common sequelae of endotracheal tube (ETT) intubation, and systemic corticosteroids are considered a mainstay treatment for this problem. Drug-eluting ETT may present an attractive option for topical steroid delivery while avoiding systemic side effects and improving the therapeutic outcome. The objective of the present study is to evaluate the reduction of tube-related tracheal morbidity via a self-designed steroid-eluting ETT with controlled sustained release properties in an animal model. Methods: steroid-eluting ETTs were coated by poly(lactic-co-glycolic acid) -electrospun nanofibers loaded with mometasone furoate (MF) as a model drug. Animals were randomly assigned into three equal groups: non-intubated, blank-ETT, and loaded-ETT. The intubation interval was 1 week. Specimens were analyzed by histology, specific fibrosis staining, and scanning electron microscopy (SEM). Results: the blank-ETT group exhibited a significant increase in tracheal mucosal thickness compared to the loaded-ETT and control groups. Average tracheal mucosal thickness was 112 ± 34, 242 ± 49, and 113 ± 43 μm in the control, blank-ETT, and loaded-ETT groups, respectively. The blank-ETT group exhibited a significant increase in tracheal fibrosis compared to the loaded-ETT and control groups. Relative fibrosis values were 0.07 ± 0.05, 0.154 ± 0.1, and 0.0984 ± 0.084% for the control, blank-ETT, and loaded-ETT groups, respectively. While SEM imaging showed normal surface structures in the control group, intubated blank-ETT rats showed severe surface structural damage, whereas only mild damage was observed in the loaded-ETT group. Conclusions: local sustained release of MF via a self-designed drug-eluting ETT is a potential therapeutic approach which may significantly reduce tube-related upper airway morbidity.
- 12 April 2021
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 4 (5) , 4131-4139
Local Delivery of Mometasone Furoate from an Eluting Endotracheal Tube Reduces Airway Morbidity Following Long-Term Animal Intubation
Background: upper airway complications are common sequelae of endotracheal tube (ETT) intubation, and systemic corticosteroids are considered a mainstay treatment for this problem. Drug-eluting ETT may present an attractive option for topical steroid delivery while avoiding systemic side effects and improving the therapeutic outcome. The objective of the present study is to evaluate the reduction of tube-related tracheal morbidity via a self-designed steroid-eluting ETT with controlled sustained release properties in an animal model. Methods: steroid-eluting ETTs were coated by poly(lactic-co-glycolic acid) -electrospun nanofibers loaded with mometasone furoate (MF) as a model drug. Animals were randomly assigned into three equal groups: non-intubated, blank-ETT, and loaded-ETT. The intubation interval was 1 week. Specimens were analyzed by histology, specific fibrosis staining, and scanning electron microscopy (SEM). Results: the blank-ETT group exhibited a significant increase in tracheal mucosal thickness compared to the loaded-ETT and control groups. Average tracheal mucosal thickness was 112 ± 34, 242 ± 49, and 113 ± 43 μm in the control, blank-ETT, and loaded-ETT groups, respectively. The blank-ETT group exhibited a significant increase in tracheal fibrosis compared to the loaded-ETT and control groups. Relative fibrosis values were 0.07 ± 0.05, 0.154 ± 0.1, and 0.0984 ± 0.084% for the control, blank-ETT, and loaded-ETT groups, respectively. While SEM imaging showed normal surface structures in the control group, intubated blank-ETT rats showed severe surface structural damage, whereas only mild damage was observed in the loaded-ETT group. Conclusions: local sustained release of MF via a self-designed drug-eluting ETT is a potential therapeutic approach which may significantly reduce tube-related upper airway morbidity.
- 30 November 2020
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 140, 110534
Pediatric acute otitis externa: Characteristics and predictors for hospital admission
- 30 November 2020
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 140, 110534
Pediatric acute otitis externa: Characteristics and predictors for hospital admission
- 7 September 2020
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 138, 110373
The effect of an interventional program on the occurrence of medication errors in children
- 7 September 2020
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 138, 110373
The effect of an interventional program on the occurrence of medication errors in children
- 1 January 2020
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 128, 109738
A novel rat model for tracheal mucosal damage assessment of following long term intubation
- 1 January 2020
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 128, 109738
A novel rat model for tracheal mucosal damage assessment of following long term intubation
- 1 September 2019
- Vol. 21 (9) , 607-611
Hearing Loss and Ophthalmic Pathology in Children Diagnosed Before and after the Implementation of a Universal Hearing Screening Program
Background: Ophthalmic pathologies may further complicate the sensory input of patients with congenital hearing loss; however, data on children with coexisting impairment of vision and hearing is outdated, from before universal implementation of hearing screening programs. Objectives: To examine the different ophthalmic pathologies among children with congenital sensorineural hearing loss (SNHL) before or after the introduction of a universal newborn hearing screening program (UNHSP). Methods: Retrospective cohort study was conducted of 91 children diagnosed with congenital SNHL between 2005 and 2016 in a tertiary pediatric hospital. All patients completed an ophthalmologic examination, including assessment of visual acuity, refraction, ocular motility, slit lamp examination, and indirect funduscopy. Radiological assessment and genetic analysis were offered to all caregivers. Results: Average age at diagnosis was 4.1 years. Nineteen children (21%) were diagnosed with an ophthalmic condition, of which the most common were refractive pathologies. Diagnosis of an ophthalmic pathology was twice as likely in the pre-UNHSP era (14 children, 27%) compared to the post-UNHSP era (5 children, 13%). Out of 91 children, 57 (63%) underwent a computed tomography scan and/or magnetic resonance imaging. Imaging was positive for structural abnormalities in 23 children (40%). There was no correlation between imaging and ophthalmic conditions. Genetic analysis was performed in 67 patients (74%). Conclusions: The ophthalmic assessment of babies and children with congenital SNHL may yield in significant numbers of children with concomitant ophthalmic pathologies. Implementation of a UNHSP allows early diagnosis and treatment of coexisting ophthalmic and hearing conditions.
- 1 September 2019
- Vol. 21 (9) , 607-611
Hearing Loss and Ophthalmic Pathology in Children Diagnosed Before and after the Implementation of a Universal Hearing Screening Program
Background: Ophthalmic pathologies may further complicate the sensory input of patients with congenital hearing loss; however, data on children with coexisting impairment of vision and hearing is outdated, from before universal implementation of hearing screening programs. Objectives: To examine the different ophthalmic pathologies among children with congenital sensorineural hearing loss (SNHL) before or after the introduction of a universal newborn hearing screening program (UNHSP). Methods: Retrospective cohort study was conducted of 91 children diagnosed with congenital SNHL between 2005 and 2016 in a tertiary pediatric hospital. All patients completed an ophthalmologic examination, including assessment of visual acuity, refraction, ocular motility, slit lamp examination, and indirect funduscopy. Radiological assessment and genetic analysis were offered to all caregivers. Results: Average age at diagnosis was 4.1 years. Nineteen children (21%) were diagnosed with an ophthalmic condition, of which the most common were refractive pathologies. Diagnosis of an ophthalmic pathology was twice as likely in the pre-UNHSP era (14 children, 27%) compared to the post-UNHSP era (5 children, 13%). Out of 91 children, 57 (63%) underwent a computed tomography scan and/or magnetic resonance imaging. Imaging was positive for structural abnormalities in 23 children (40%). There was no correlation between imaging and ophthalmic conditions. Genetic analysis was performed in 67 patients (74%). Conclusions: The ophthalmic assessment of babies and children with congenital SNHL may yield in significant numbers of children with concomitant ophthalmic pathologies. Implementation of a UNHSP allows early diagnosis and treatment of coexisting ophthalmic and hearing conditions.
- 1 February 2019
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 117, 171-174
Occult malignancy in pediatric tonsil and adenoid surgeries – A national survey
- 1 February 2019
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 117, 171-174
Occult malignancy in pediatric tonsil and adenoid surgeries – A national survey